美国前禁毒署长拉胡尔·古普塔博士加入GATC Health担任总裁-动脉网

Former U.S. Drug Czar Dr. Rahul Gupta Joins GATC Health as President

CISION 等信源发布 2025-05-01 22:30



可切换为仅中文







Dr. Gupta, Director, White House Office of National Drug Control Policy (2021-2025), to lead AI-powered drug discovery group.

古普塔博士，白宫国家药物管制政策办公室主任（2021-2025），将领导人工智能驱动的药物发现团队。

IRVINE, Calif.

加利福尼亚州欧文市

，

May 1, 2025

2025年5月1日

/PRNewswire/ -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, is proud to announce that Dr.

/PRNewswire/ -- GATC Health Corp是一家利用人工智能（AI）转变药物发现的领先技术生物公司，自豪地宣布Dr.

Rahul Gupta

, MD, MPH, MBA, has joined the company as its new president. GATC Health, a trailblazer in tech-bio innovation, is leveraging cutting-edge artificial intelligence (AI) to revolutionize the field of drug discovery. Dr. Gupta's exceptional career in public health leadership, medical innovation, and policy development brings unparalleled expertise to guide GATC Health as it embarks on its next phase of strategic growth..

医学博士、公共卫生硕士、工商管理硕士加入了公司，成为其新任总裁。GATC Health 作为技术生物创新的先驱，正在利用尖端的人工智能 (AI) 革新药物发现领域。古普塔博士在公共卫生领导、医疗创新和政策制定方面的卓越职业生涯，为指导 GATC Health 进入其战略增长的下一阶段带来了无与伦比的专业知识。

继续阅读

Dr. Rahul Gupta, President of GATC Health

GATC Health总裁拉胡尔·古普塔博士

Executing GATC Health's Strategic Vision

执行GATC健康的战略愿景

Dr. Gupta's forward-thinking policies while at the White House delivered a remarkable turnaround in overdose deaths,

古普塔博士在白宫期间富有前瞻性的政策显著扭转了药物过量致死的局面，

saving over 27,000 lives

挽救超过27,000人的生命

in 2024—a 24% decrease year over year. During this time, Dr. Gupta recognized that a non-opioid alternative could be revolutionary in treating opioid use disorder and keeping more Americans alive.

2024年，这一数字同比下降了24%。在此期间，古普塔博士认识到，非阿片类替代品可能在治疗阿片类药物使用障碍和挽救更多美国人的生命方面具有革命性意义。

Interested in extending his life-saving legacy, Dr. Gupta accepted the position of President at GATC Health, where he will work closely with the executive leadership team and the board of directors to refine and implement the company's strategic vision. His leadership will be instrumental in expanding global partnerships while championing GATC Health's advanced AI technology on both national and international platforms.

出于对延续其救命事业的兴趣，古普塔博士接受了GATC Health总裁一职。他将与执行领导团队和董事会密切合作，完善并实施公司的战略愿景。他的领导对于拓展全球合作关系，以及在国家和国际平台上推动GATC Health的先进人工智能技术将发挥重要作用。

Dr. Gupta's insights will enhance commercialization strategies, industry thought leadership, and market development as GATC Health continues to deliver impactful, AI-driven solutions in drug discovery and development..

GATC Health将继续在药物发现和开发领域提供有影响力的、由人工智能驱动的解决方案，Gupta博士的见解将加强商业化战略、行业思想领导力和市场发展。

'Dr. Gupta's remarkable expertise and forward-thinking approach make him the perfect leader to join our team as we guide GATC Health into its next transformative chapter,' said

“古普塔博士的卓越专业知识和前瞻性方法使他成为加入我们团队的完美领导者，带领GATC Health进入下一个变革性的篇章，”

Jayson Uffens

杰森·乌芬斯

, Chief Technology Officer of GATC Health. 'Our Multiomics Advanced Technology platform has already proven its ability to significantly reduce drug discovery timelines, lower costs, and mitigate risk. With Dr. Gupta's leadership, we are poised to accelerate the delivery of innovative therapies that address some of the most pressing health challenges of our time.'.

GATC Health的首席技术官表示：“我们的多组学先进技术平台已经证明了其能够显著缩短药物发现时间、降低成本并减轻风险。在古普塔博士的领导下，我们准备加速推出应对当今最紧迫健康挑战的创新疗法。”

Recent Policy Favors AI

近期政策利好人工智能

In response to the recent announcements by the

针对最近的公告，

FDA

食品药品监督管理局

，

EPA

美国环保署

and

和

NIH

美国国立卫生研究院

concerning the reduction and eventual elimination of animal testing in favor of new approach methodologies (NAMs), including AI, Dr. Gupta will be instrumental in helping GATC navigate the new regulatory landscape and maximizing the company's impact on drug discovery, development and funding.

关于减少并最终消除动物测试，转而采用包括人工智能在内的新方法（NAMs），古普塔博士将对帮助GATC应对新的监管环境并在药物发现、开发和资金方面最大化公司影响力起到关键作用。

'The world is rapidly changing with regard to drug development due to an explosion of AI, and the FDA must change along with it,' commented Dr.

“由于人工智能的爆炸式发展，世界在药物开发方面正在迅速变化，FDA也必须随之改变，”博士评论道。

Richard Schatz

理查德·沙茨

, GATC advisor and co-inventor of the coronary stent. 'Breakthrough technology from GATC along with the leadership of Dr.

，GATC顾问及冠状动脉支架的共同发明人。“GATC的突破性技术以及Dr.的领导。

Rahul Gupta

has rewritten the book on drug development. The ability to not only tell what drugs will work and which won't, or to repurpose drugs based on multiomics, is unique and game-changing. It is so accurate that it will likely eliminate animal testing and possibly phase one testing in humans. The net effect will be more rapid FDA approval, thus a reduction in time and cost to get drugs through.

已经重写了药物研发的规则。不仅能够预测哪些药物有效，哪些无效，还可以基于多组学重新定位药物，这一能力是独一无二且改变游戏规则的。它的准确性如此之高，以至于可能消除动物实验，甚至可能取代人类的第一阶段试验。最终结果将是加快FDA审批，从而减少药物研发的时间和成本。

All of this benefits the consumer on many levels.'.

所有这些都在许多层面上使消费者受益。

'Dr Gupta's unique past experience in the acceleration of availability of naloxone for opioid overdose saved countless lives already and places him at the epicenter of novel approaches to drug development,' Schatz added. 'His leadership will ensure that GATC fulfills its mission to bring better drugs to the market faster and cheaper.'.

“古普塔博士在过去加速纳洛酮用于阿片类药物过量使用的独特经验已经挽救了无数生命，并使他处于药物开发新方法的中心，”沙茨补充道。“他的领导将确保GATC履行其使命，更快、更便宜地将更好的药物推向市场。”

About Dr.

关于博士

Rahul Gupta

Dr. Gupta is a board-certified internist with over 25 years of experience as a practicing physician, researcher-innovator, public health official, and global health advocate. From

古普塔博士是一位拥有超过25年经验的内科医生，同时也是执业医师、研发者、公共卫生官员和全球健康倡导者。

November 2021

2021年11月

至

January 2025

2025年1月

, Dr. Gupta served as the first medical doctor to lead the White House Office of National Drug Control Policy (ONDCP) as its Director. As the senate confirmed and senior most drug policy advisor to the President of

，古普塔博士作为白宫国家药物管制政策办公室（ONDCP）的主任，是首位领导该机构的医学博士。他作为参议院确认的总统高级毒品政策顾问，

the United States

美国

, he coordinated the nation's

，他协调了国家的

$44 billion

440亿美元

drug budget across 19 federal agencies. Working at the intersection of national security, international diplomacy, economic policy and public health, Dr. Gupta is widely credited with achieving the most significant progress in the drug overdose crisis in American history.

横跨19个联邦机构的药物预算。古普塔博士在国家安全、国际外交、经济政策和公共卫生的交汇处工作，被广泛认为在美國历史上取得了应对药物过量危机的最重大进展。

'I am truly honored to join GATC Health at this pivotal moment in the company's journey and in the evolution of the biotech industry as a whole,' said Dr. Gupta. 'The transformative potential of the Multiomics Advanced Technology platform is nothing short of revolutionary. By harnessing the power of AI to simulate the complexities of human biochemistry, GATC Health is poised to reshape the landscape of healthcare delivery and drug discovery.

“我非常荣幸能够在公司发展的关键时刻加入GATC Health，也正值生物技术行业整体演变的重要阶段，”古普塔博士说道。“多组学先进技术平台的变革潜力无疑具有革命性。通过利用人工智能来模拟人类生物化学的复杂性，GATC Health有望重塑医疗交付和药物发现的格局。”

I am eager to work alongside this extraordinary team to accelerate breakthroughs that will not only advance science but also dramatically improve patient outcomes and quality of life.'.

我渴望与这个非凡的团队合作，加速突破，这不仅将推动科学发展，还将显著改善患者的治疗效果和生活质量。

Through his work as a physician, policy maker, an educator, and a global innovator, Dr. Gupta has dedicated his career to improving public health and public safety. Previously, his passion for global health led him to join the March of Dimes as Chief Medical and Health Officer and Senior Vice President, where he provided strategic oversight for the organization's domestic and global medical and public health efforts.

通过他作为医生、政策制定者、教育家和全球创新者的工作，古普塔博士致力于改善公共卫生和公共安全。此前，他对全球健康的热情促使他加入美国出生缺陷基金会，担任首席医疗和卫生官兼高级副总裁，在那里他为该组织的国内和全球医疗及公共卫生工作提供了战略监督。

He has served as a local public health official and as the West Virginia Health Commissioner under two governors, where he brought together public health, law enforcement, healthcare, faith-based, business, and other community partners to solve local problems in novel and innovative ways. He has supported the expansion of programs to marginalized and under-served communities both in .

他曾担任地方公共卫生官员和西弗吉尼亚州两位州长下的卫生专员，在任期间，他汇聚了公共卫生、执法、医疗保健、信仰组织、商业及其他社区合作伙伴，以新颖创新的方式解决当地问题。他还支持扩大对边缘化和未充分服务社区的项目覆盖。

the United States

美国

and across the world.

并且跨越全世界。

Dr. Gupta has held academic appointments at

古普塔博士曾在以下机构担任学术职务

Georgetown University School of Medicine

乔治敦大学医学院

and

和

Harvard University

哈佛大学

and holds degrees from the University of

并持有来自大学的学位

Delhi

德里

，

University of Alabama-Birmingham

阿拉巴马大学伯明翰分校

, and the

，以及

London School of Business

伦敦商学院

and Finance.

和财政。

About GATC Health

关于GATC健康

GATC Health Corp. is a technology company transforming drug discovery and development through its AI-driven platform and approach. The company's validated and proprietary Multiomics Advanced Technology™ (MAT) simulates human biochemistry's billions of interactions to rapidly create novel therapeutics, identify and confirm targets, accelerate development, and de-risk drug pipelines by predicting efficacy, safety, and off-target effects..

GATC Health Corp是一家技术公司，通过其人工智能驱动的平台和方法革新药物发现与开发。该公司经过验证且专有的多组学先进技术™（MAT）模拟人类生物化学数十亿种相互作用，以快速开发新型疗法、识别并确认靶点、加速开发进程，并通过预测疗效、安全性和脱靶效应来降低药物研发风险。

For more information, visit

欲了解更多信息，请访问

www.gatchealth.com

。

SOURCE GATC Health Corp

来源：GATC健康公司

WANT YOUR COMPANY'S NEWS

想要你公司的新闻吗

FEATURED ON PRNEWSWIRE.COM?

刊登在PRNEWSWIRE.COM上？

440k+